J. Pihlajamaki

发表

Association of fatty liver index with risk of incident type 2 diabetes by metabolic syndrome status in an Eastern Finland male cohort: a prospective study

T. Tuomainen, J. Virtanen, O. Olubamwo, 2019, BMJ Open.

Associations of I148M variant in PNPLA3 gene with plasma ALT levels during 2‐year follow‐up in normal weight and overweight children: the PANIC Study

T. Lakka, M. Atalay, R. Joro, 2015, Pediatric obesity.

Fatty liver index as a predictor of increased risk of cardiometabolic disease: finding from the Kuopio Ischaemic Heart Disease Risk Factor Study Cohort

T. Tuomainen, J. Virtanen, O. Olubamwo, 2019, BMJ Open.

Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis.

D. Prati, E. Bugianesi, S. Fargion, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Plasma IL-1 receptor antagonist levels correlate with the development of non-alcoholic steatohepatitis.

M. Hofker, S. Kalhan, P. J. V. van Gorp, 2015, Biomarkers in medicine.

Increase or Decrease ? Effect of Cold Air on Exercise Capacity in

H. Pekkarinen, H. Koskela, H. Tukiainen, 2007 .

Reply to "Statin treatment for non-alcoholic steatohepatitis".

L. Valenti, S. Romeo, P. Dongiovanni, 2016, Journal of hepatology.

Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism

J. Holst, J. Auwerx, M. Patti, 2009, Obesity.

PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients patient-oriented and epidemiological research

L. N. Valenti, V. Ranzani, S. Fargion, 2020 .

Rare ATG7 genetic variants predispose patients to severe fatty liver disease.

L. N. Valenti, H. Reeves, V. Vaira, 2022, Journal of hepatology.

Statin use and non-alcoholic steatohepatitis in at risk individuals.

Marco Maggioni, Stefano Romeo, Luca Valenti, 2015, Journal of hepatology.

PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients[S]

V. Ranzani, M. Ruscica, S. Fargion, 2019, Journal of Lipid Research.

Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver

L. Carlsson, S. Stender, A. Craxì, 2017, Journal of internal medicine.

https://doi.org/10.1194/jlr.P090449 PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD contains a supplement. patient-oriented

L. Valenti, S. Fargion, G. Baselli, 2019 .